GE HealthCare Technologies Inc. (GEHC)
Healthcare · Medical - Devices · Data as of 2026-10-22
Bottom line
GEHC is trading near its usual valuation, near its historical support zone, and recent volume suggests money flowing in. Historically, this combination has been a favourable starting point for further research. Past patterns are not a guarantee of future results.
Valuation — Trading near its usual range (Yellow)
GEHC trades at 20× earnings, above its own 5-year average of 16× and below similar healthcare companies we track (28×, 53 peers). That is roughly what the market has typically paid for this stock. Its free-cash-flow yield is about 2.9%. Its current multiple sits around the 43rd percentile of its own last five years — around the middle of its own range. About 57% of its reported earnings arrived as free cash over the last year.
Price zones — Near its historical support zone (Green)
At $71.42, the stock is close to the lower end of its recent range. Over the past year GEHC has traded between $58.75 and $89.77; its historical support zone sits near $70.19 and resistance near $89.77. It is above both its 50- and 200-day averages, which has historically signalled an uptrend.
52-week range $58.75–$89.77 · 50-day average $68.41 · 200-day average $70.19
Money flow — Money is flowing in (Green)
Recent trading in GEHC shows more volume on rising days than falling days, a pattern often described as accumulation. Volume on up days has been about 1.0× volume on down days over the last 30 sessions.
Dividends & company facts
GEHC paid $0.18 a share in dividends over the past year — 0.25% of today's price — and raised it 2 times in the last five years. It returned more through buybacks: $163 million in fiscal 2025, about 0.52% of its market value.
- Dividend yield (12 months)
- 0.25%
- Paid over 12 months
- $0.18 a share
- Payout ratio
- 4.0%
- Buybacks
- 0.52% (fiscal 2025)
- Shares, past year
- -0.9%
- Revenue, 12 months
- $20.2B
- Profit, 12 months
- $1.6B
- Employees
- 54,000
- CEO
- Peter J. Arduini
- Headquarters
- Chicago, IL
- Listed since
- 2022 · NASDAQ
About the company
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients.
Related stocks
一句话结论
GEHC 估值接近其惯常水平，接近其历史支撑区，近期成交量显示资金正在流入。从历史来看，这样的组合是一个值得进一步研究的有利起点。过去的形态并不能保证未来的结果。
估值 — 处于其惯常的估值区间
GEHC 目前的市盈率为 20×，高于其自身 5 年平均的 16×，并且低于我们追踪的同类Healthcare公司（28×，53 家）。这大致就是市场以往为这只股票所付出的水平。其自由现金流收益率约为 2.9%。它当前的估值倍数大约位于自身过去五年分布的第 43 百分位——处于自身区间的中部。过去一年，其报告利润中约有 57% 转化为自由现金。
价格区间 — 接近其历史支撑区
目前价格为 $71.42，接近其近期区间的下沿。过去一年 GEHC 的价格在 $58.75 到 $89.77 之间波动；其历史支撑区在 $70.19 附近，阻力区在 $89.77 附近。它同时位于 50 日和 200 日均线上方，这在历史上通常对应上升趋势。
资金流向 — 资金正在流入
GEHC 近期上涨日的成交量高于下跌日，这种形态常被称为吸筹。过去 30 个交易日，上涨日的成交量约为下跌日的 1.0×。
股息与公司概况
GEHC 过去一年每股派息 0.18 美元，相当于当前股价的 0.25%，过去五年上调过 2 次。它通过回购返还了更多：2025 财年回购 1.6亿美元，约占市值的 0.52%。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.